Table 1 Patients’ characteristics

From: A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells

 

No. on TMA

Fraction on the total (%)

Age, years

 ⩽49

119

2.9

 50–60

1072

26.0

 60–70

2630

63.8

 >70

302

7.3

Preoperative PSA, ng ml −1

 <4

642

15.7

 4–10

2324

56.9

 10–20

826

20.2

 >20

290

7.1

pT stage (AJCC 2002)

 pT2

2745

66.4

 pT3

1343

32.5

 pT4

45

1.1

Gleason score

 ⩽3+3

1680

40.7

 3+4

1866

45.2

 4+3

458

11.1

 ⩾4+4

124

3.0

N stage

 pN0

2094

50.8

 pN+

159

3.9

 pNx

1869

45.3

Surgical margin status

 R0

3299

80.2

 R1

809

19.6

 RX

7

0.2

PSA recurrence

 Event

913

21.9

 No event

3264

78.1

Metastatic onset

 Event

137

3.3

 No event

4040

96.7

  1. Abbreviations: AJCC, American Joint Committee in Cancer; TMA, tissue microarray.
  2. Note: Numbers do not always add up to 4177 in the different categories because of cases with missing data.
Back to article page